2018
DOI: 10.1002/cam4.1285
|View full text |Cite
|
Sign up to set email alerts
|

Contribution of MLH1 constitutional methylation for Lynch syndrome diagnosis in patients with tumor MLH1 downregulation

Abstract: Constitutional epimutation of the two major mismatch repair genes, MLH1 and MSH2, has been identified as an alternative mechanism that predisposes to the development of Lynch syndrome. In the present work, we aimed to investigate the prevalence of MLH1 constitutional methylation in colorectal cancer (CRC) patients with abnormal expression of the MLH1 protein in their tumors. In a series of 38 patients who met clinical criteria for Lynch syndrome genetic testing, with loss of MLH1 expression in the tumor and wi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
20
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 30 publications
(24 citation statements)
references
References 41 publications
1
20
0
Order By: Relevance
“…In addition, about 5%-15% of colorectal carcinomas (CRCs) display reduced MLH1 immunostaining and MMR deficiency due to promoter hypermethylation. In most cases, epigenetic inactivation is a somatic event, but constitutional MLH1 hypermethylation has been reported in several patients [125][126][127][128]. Overall, this mechanism explains 1.5%-10.5% of CRCs associated with abnormal expression of MLH1, and might account for up to 3% of LS [128].…”
Section: Lynch Syndromementioning
confidence: 99%
See 2 more Smart Citations
“…In addition, about 5%-15% of colorectal carcinomas (CRCs) display reduced MLH1 immunostaining and MMR deficiency due to promoter hypermethylation. In most cases, epigenetic inactivation is a somatic event, but constitutional MLH1 hypermethylation has been reported in several patients [125][126][127][128]. Overall, this mechanism explains 1.5%-10.5% of CRCs associated with abnormal expression of MLH1, and might account for up to 3% of LS [128].…”
Section: Lynch Syndromementioning
confidence: 99%
“…In most cases, epigenetic inactivation is a somatic event, but constitutional MLH1 hypermethylation has been reported in several patients [125][126][127][128]. Overall, this mechanism explains 1.5%-10.5% of CRCs associated with abnormal expression of MLH1, and might account for up to 3% of LS [128]. In a few cases, the epigenetic abnormality is accompanied by deletions or single nucleotide substitutions, namely a specific MLH1 haplotype bearing the variants c.27C>A and c.85G>T (secondary epimutation), and inheritance of these genetic variations and associated epimutation has been observed in some families [129].…”
Section: Lynch Syndromementioning
confidence: 99%
See 1 more Smart Citation
“…Our MS-MCA approach allowed the robust and highly sensitive detection of MLH1 methylation in blood, whereas no evidence of methylation was detected in controls. In contrast, pyrosequencing and MS-MLPA, widely used in clinical diagnostics for MLH1 methylation detection [12,14,23,24], display a lower analytical sensitivity (5-10%) than MS-MCA (1%) [19], potentially overlooking low-level epigenetic mosaicism. Moreover, the background signal observed in pyrosequencing analyses could account for the high proportion (78%) of low-level (< 10%) methylation levels previously reported in healthy controls [17].…”
Section: Discussionmentioning
confidence: 99%
“…Ninety-seven index cases with a constitutional MLH1 epimutation have been reported so far [8][9][10][11][12]. Most are considered primary, arising apparently de novo and reversible between generations, whereas secondary epimutations are associated with a genetic variant in cis.…”
Section: Introductionmentioning
confidence: 99%